TrialJournal of clinical immunology2004

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study.

C L Cooper et al.PubMed ↗Publisher ↗

No numbers read from the abstract.